Impact of CD34+ Stem Cell Dose on Engraftment Period in Allogeneic Peripheral Blood Stem Cell Transplanted Patients

Haematopoietic progenitor stem cells acquired from the peripheral blood have been increasingly used to treat patient with haematological malignancy. The success of the allogeneic peripheral blood stem cell transplantation (PBSCT) is significantly dependent on amount of CD34+ stem cell infused which...

Full description

Saved in:
Bibliographic Details
Published inMedicine & health (Kuala Lumpur, Malaysia) Vol. 16; no. 1; pp. 39 - 49
Main Author Abdul Aziz, Suria
Format Journal Article
LanguageEnglish
Published 28.06.2021
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first